Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L: Phase II Open Label, Single Arm Multi-Centre Trial

Abstract excerpt

BACKGROUND: Ectopic pregnancies are a leading cause of maternal mortality. Most are treated surgically. We evaluated the efficacy and safety of combining oral gefitinib (epidermal growth factor receptor inhibitor) with methotrexate to treat larger ectopic pregnancies. METHODS: ) once, and oral gefitinib (250 mg) for seven days. The primary outcome was the percentage successfully treated without needing surgery....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ectopic Pregnancy Diagnosis and Management
• Share to Gestational Trophoblastic Disease Studies
• Share to Gynecological conditions and treatments